After local control
After local treatment of uveal melanoma: what comes next?
Local control is necessary but does not eliminate systemic risk. After ocular treatment the focus shifts to metastatic risk and surveillance planning.
For patients and clinicians
Three questions after treatment
What is the risk?
Clinical/anatomical features and, when available, molecular prognostic testing.
How should follow-up be organised?
The plan should reflect risk and liver-focused assessment.
What would be actionable?
The goal is not just earlier detection but a chance to change the pathway.
Important: earlier detection should not be presented as automatically proven to improve overall survival.